TRK-IN-25

• Description :

  TRK-IN-25 (compound 16) is a Trk inhibitor with antiproliferative activity against cancer cells. TRK-IN-25 can be used in cancer research[1].

• UNSPSC :

  12352005

• Target :

  Trk Receptor

• Type :

  Reference compound

• Related Pathways :

  Neuronal Signaling; Protein Tyrosine Kinase/RTK

• Applications :

  Cancer-Kinase/protease

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/trk-in-25.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(C1=CC=C(N(C2=CC=C(C=C2)F)C1=O)OC(C)C)NC3=CC=C(C(F)=C3)OC4=CC5=C(C=C4C6=CNN=C6)N(C)N=C5

• Molecular Formula :

  C32H26F2N6O4

• Molecular Weight :

  596.58

• References & Citations :

  [1]Boyu Zhong, et al. Trk inhibitor as anti-cancer drug. Patent WO2020048455A1.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [2412309-60-3]